EP3730138
COMBINATION OF SEPETAPROST AND RIPASUDIL FOR USE IN THE PROPHYLAXIS OR TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.12.2018EP published:
14.2.2024EP application number:
18891292.7
EPO information:
European Patent Register
Max expiry date:
19.12.2038
Title in English:
COMBINATION OF SEPETAPROST AND RIPASUDIL FOR USE IN THE PROPHYLAXIS OR TREATMENT OF GLAUCOMA OR OCULAR HYPERTENSIONLanguage of the patent:
English
Timeline
Today
20.12.2018EP application
14.2.2024EP Publication
Owner
Name:
Santen Pharmaceutical Co., Ltd.Address:
4-20, Ofuka-cho, Kita-ku Osaka-shi Osaka 530-8552, JP
Inventor
Name:
YAMAMOTO YasukoAddress:
Ikoma-shi, Nara 630-0101, JP
Name:
TANIGUCHI TakazumiAddress:
Ikoma-shi, Nara 630-0101, JP
Priority
Number:
2017244847Date:
21.12.2017Country:
JP
Number:
2018180658Date:
26.9.2018Country:
JP
Classification
Categories:
A61K 31/558, A61K 31/551, A61P 43/00, A61P 27/06, A61P 27/02, A61P 9/12, A61K 45/00, A61K 31/472, A61K 31/335, A61K 45/06